Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Thermo Fisher Scientific



) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole was unchanged today. By the end of trading, Thermo Fisher Scientific fell $1.30 (-1.1%) to $119.35 on heavy volume. Throughout the day, 3,934,027 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2,510,100 shares. The stock ranged in price between $117.08-$122.42 after having opened the day at $121.22 as compared to the previous trading day's close of $120.65. Other companies within the Health Services industry that declined today were:




), down 13.1%,

Response Genetics



), down 9.4%,

Foundation Medicine



), down 8.1% and

Oculus Innovative



), down 6.8%.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics in the United States and internationally. Thermo Fisher Scientific has a market cap of $48.2 billion and is part of the health care sector. Shares are up 8.3% year to date as of the close of trading on Monday. Currently there are 14 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates

Thermo Fisher Scientific

as a


. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front,

BG Medicine



), up 22.4%,

Bovie Medical Corporation



), up 15.0%,




), up 10.9% and

Escalon Medical Corporation



), up 8.8% , were all gainers within the health services industry with

Baxter International



) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care




STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.